US Broker Ratings

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Potential 30.79% Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in the development of innovative medical devices, particularly for patients suffering from obstructive sleep apnea (OSA)...

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 41.94% Potential Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotechnology sector with its promising pipeline and robust analyst support. The clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is focused..

BrightSpring Health Services (BTSG): Analyst Consensus Reveals Strong Buy Ratings and 8.3% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a formidable player in the U.S. healthcare market, operates within the Health Information Services industry. With a market capitalization of $7.41 billion, the company has..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights 248% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the biotechnology sector, is drawing attention with its significant potential upside of 248.08%, as revealed by recent analyst ratings. As a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its remarkable 434% revenue growth, underscoring its potential in the burgeoning biotechnology sector. As a biopharmaceutical company specializing..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook on Promising Gene Therapy Potential and 13.53% Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector with its innovative RNA-targeted therapeutics and gene therapies aimed at treating rare diseases like Duchenne muscular dystrophy...

Viatris Inc. (VTRS) Investor Outlook: Navigating a 3.02% Dividend Yield Amidst Healthcare Opportunities

For individual investors eyeing the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents an intriguing case. With a market capitalization of $18.38 billion, Viatris operates as a major player in the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27% Upside Potential with Robust Growth Prospects

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with a promising upside potential of 27.42%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 42.11% Upside Potential with a Strong Buy Consensus

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector, capturing investor attention with its focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts, this commercial-stage biopharmaceutical company is..

Halozyme Therapeutics (HALO) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to drug delivery and impressive financial metrics. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, presents a compelling opportunity for investors who are keen to explore the evolving landscape of healthcare plans in the United States...

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 73% Potential Upside in the Healthcare Sector

For investors with an eye for opportunity in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. Headquartered in Italy, this company operates within the medical instruments..

Henry Schein, Inc. (HSIC) Stock Analysis: A Comprehensive Look at Growth Potential Amidst Healthcare Distribution Dynamics

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the medical distribution sector, has carved out a significant niche by providing a wide array of healthcare products and services. With..

Globus Medical, Inc. (GMED): Investor Outlook and Growth Potential Amid Strong Analyst Consensus

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative solutions for musculoskeletal disorders. Headquartered in Audubon,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: An Investor’s Guide to a Promising 17% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare market’s innovative edge. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Report: Unpacking a 183.83% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is captivating investor attention with its robust pipeline of diagnostic and therapeutic radiopharmaceuticals. Headquartered in North Melbourne, Australia,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 19.42% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves in the investor community with a promising potential upside of 19.42%. With a market capitalization of..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility in a $14.42 Billion Healthcare Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience company, stands at the intersection of healthcare innovation and market volatility. With a market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Uncovering an 8% Potential Upside in the Medical Devices Sector

As investors navigate the dynamic landscape of the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) emerges as a noteworthy player in the medical devices industry. With a market capitalization of..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with a 7.41% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering player in the healthcare sector, is redefining the organ transplant landscape with its groundbreaking Organ Care System (OCS). This innovative technology company, headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds